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Abstract
Background: The Clinical Outcomes in Routine Evaluation - Outcome Measure (CORE-OM) is a 34-item instrument
developed to monitor clinically significant change in out-patients. The CORE-OM covers four domains: well-being,
problems/symptoms, functioning and risk, and sums up in two total scores: the mean of All items, and the mean of
All non-risk items. The aim of this study was to examine the psychometric properties of the Norwegian translation
of the CORE-OM.
Methods: A clinical sample of 527 out-patients from North Norwegian specialist psychiatric services, and a non-clinical
sample of 464 persons were obtained. The non-clinical sample was a convenience sample consisting of friends and
family of health personnel, and of students of medicine and clinical psychology. Students also reported psychological
stress. Exploratory factor analysis (EFA) was employed in half the clinical sample. Confirmatory (CFA) factor analyses
modelling the theoretical sub-domains were performed in the remaining half of the clinical sample. Internal
consistency, means, and gender and age differences were studied by comparing the clinical and non-clinical
samples. Stability, effect of language (Norwegian versus English), and of psychological stress was studied in the
sub-sample of students. Finally, cut-off scores were calculated, and distributions of scores were compared
between clinical and non-clinical samples, and between students reporting stress or no stress.
Results: The results indicate that the CORE-OM both measures general (g) psychological distress and sub-domains, of
which risk of harm separates most clearly from the g factor. Internal consistency, stability and cut-off scores compared
well with the original English version. No, or only negligible, language effects were found. Gender differences were
only found for the well-being domain in the non-clinical sample and for the risk domain in the clinical sample. Current
patient status explained differences between clinical and non-clinical samples, also when gender and age were
controlled for. Students reporting psychological distress during last week scored significantly higher than students
reporting no stress. These results further validate the recommended cut-off point of 1 between clinical and non-clinical
populations.
Conclusions: The CORE-OM in Norwegian has psychometric properties at the same level as the English original, and
could be recommended for general clinical use. A cut-off point of 1 is recommended for both genders.
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Background
Valid instruments for systematic routine outcome meas-
urement may be key tools for preventing treatment failure
in psychotherapy [1,2]. The clinical value of outcome-
scores gained through translated instruments depends
upon that both content and test-parameters are compar-
able to the original language version, that the scale scores
are sensitive to change in subjective psychological stress,
and finally, upon whether the tool separates a clinical
sample from a non-clinical sample [3].
The Clinical Outcomes in Routine Evaluation-Outcome
measure (CORE-OM) was developed to track the status
of patient mental health problems through the course of
outpatient treatment [4,5]. Items were carefully chosen
according to their clinical significance and to their
likeliness to change during recovery. The items cover
four domains: well-being, problems/symptoms, func-
tioning and risk. Well-being depicts the affective tone,
and the quality of life of the patient. Problems/symptoms
include the most common symptoms of anxiety and
depression, aftermath of trauma, and physical correlates
of psychological health. Functioning indicates function-
ing in daily life, in general, as well as in social and close
relations. Risk covers self-harm and suicidal ideation, as
well as threats of violence, and perpetrated violence
against others. The first three domains correspond with
the phase model for psychotherapy change [6], which
entails progressive improvement, firstly by improved
well-being, secondly by reduction in symptoms, and,
finally, by enhancement of life functioning. The fourth
domain, risk, was chosen to assist the clinician in moni-
toring the most adverse outcome, namely signs of risk
of suicide, self-harm and violence in patients with
mental health problems.
The three first CORE domains (well-being, problems
and functioning), have been found to be highly corre-
lated, while the risk domain shows more moderate cor-
relations with the other domains [7-9]. Two studies of
the factor structure of the original English CORE-OM
have not confirmed the theoretical model of four inde-
pendent domains [9,10]. Lyne and colleagues [9] found
evidence that the 34 items shared a g (general) factor of
psychological distress, with residual wellbeing, prob-
lems, functioning, risk factors, and finally, separate
factors for positively and negatively worded items. They
did however find evidence that the risk items separated
into “risk to self” and “risk to others”, and together
formed a separate factor, important for clinical flagging
of risk of harm. They also looked for gender differences
in factor structure, and found that although present,
gender differences were of little clinical significance.
Consequently, Lyne and colleagues [9] concluded with a
recommendation for using CORE-OM as a two-scale
instrument: one general scale measuring psychological
distress, and containing all non-risk items, and one scale
containing the risk items. In the same line, using princi-
pal component analyses (PCA) and Mokken scaling,
Bedford and colleagues [10] demonstrated a two-factor
structure of the CORE-OM, and argued for shortening
the scale. The high internal consistency of the distress
factor clearly indicated that the CORE-OM contained
redundant items. Bedford and colleagues [10] raised the
question whether the CORE not only measured the state
during the last week, but also touched upon stable
traits, in other words that the CORE also measured
personality factors [11].
The Norwegian translation of CORE-OM was conducted
in 2001, and was the first approved translation of the
CORE-OM. At present approved translations of the
CORE-OM exist in most European languages. Scientific
validations have hitherto been published of the Italian
[12], the Swedish [7] and Japanese translations [13]. The
test-retest stability of the CORE-OM has been found
acceptable in the Swedish [7], the English [8] and the
Japanese [13] language versions. Convergent validity of
the CORE-OM towards measures of anxiety and depres-
sion has also been found acceptable [7,8,12,13]. Elfström
and colleagues [7] also demonstrated through a language
experiment, presenting alternate Swedish and English ver-
sions of the CORE-OM to a student sample, that language
did not influence the scores, thereby further validating the
content of the Swedish version.
Sensitivity to change in symptomatology and stress is
important for an outcome measure. In the British valid-
ation of the CORE-OM, studying cut-off points for clin-
ically significant change, Evans and colleagues [8] found
that females had higher or equal scores compared to
men on all scales, except risk, for which men scored
higher. The total score cut-off point was 1.2 for men
and 1.3 for women. In a more recent study Connell and
colleagues [14] argued for rounding the clinical cut-off
score down to 1.0 for both sexes by demonstrating that
this clinical cut-off separates between patients and non-
distressed asymptomatic individuals from the general
population. The Swedish validation [7] of CORE-OM
also demonstrated that CORE is sensitive to change in a
patient sample during out-patient treatment.
The aims of this paper were to study the psychometric
properties of the Norwegian version of the CORE-OM:
(i) by exploring and confirming the factor structure of
the Norwegian CORE-OM;
(ii)by exploring the internal consistency and test-retest
stability;
(iii)by studying the influence of current patient status,
gender and age;
(iv) by calculating cut-off points for clinical significant
change;
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(v) by studying the influence of language;
(vi) and, finally, by studying differences in CORE-OM
scores according to subjects’ report of recent
psychological stress.
Methods
Translation procedure
The translation into Norwegian was undertaken by Vidje
Hansen (VH), an experienced psychiatrist and fluent in
English. The Norwegian translation was then back-
translated to English by a professional translator, and
the two English versions were compared and discussed
between VH and Chris Evans (CE), who is an experi-
enced psychiatrist and a natural-born Englishman, and
one of the creators of the CORE-OM. The agreed-upon
Norwegian version was then tested out in a non-clinical
and a clinical sample. Some minor adjustments were
done, based upon respondents comments on readability
of the items.
Samples
A clinical sample (N=527) was collected from public out-
patient mental health services in the counties of Finnmark
(n=331), and the county of Nordland (n= 186), and from
an out-patient university clinic at the Department of
Psychology at the University of Tromsø (n=10). Altogether
the clinical sample was constituted by 320 women and
207 men, with a mean age 37.4 (SD 12.6).
A non-clinical sample (N= 464) was collected from
different sources: a convenience-sample recruited among
family and friends of employees at out-patient mental
health services in Finnmark county (n=182), a sample of
medical students at the University of Tromsø (n=209),
psychology students from the same university (n=61),
and individuals attending a course aimed at passengers
with fear of flying (n=12), altogether 333 women and
131 men. Mean age was 32.6 (SD 14.3).
A sub-sample of 81 medical and psychology students,
fluent in both Norwegian and English language, parti-
cipated in a “rotation experiment”. These bi-lingual stu-
dents were assigned to four groups. These groups
completed the CORE-OM in Norwegian and English
language version, in different sequences (i.e. Norwegian-
English-English-Norwegian; English-Norwegian-English-
Norwegian, etc.), four times with one-week interval. The
same sub-sample was also used for the for the test-retest
reliability calculations.
Consent
All sub-samples were informed in writing, according to
the regulations laid down by the Regional Committee
for Medical and Health Research Ethics in Health
Region North (REC North) for this specific project, and
return of the CORE-OM form was accepted as consent
to participate in the project. All subjects were above 18
years of age.
Ethics
The study was performed in compliance with the Helsinki
Declaration for research on humans, and was approved by
the REC North (Reference number 82/2004).
Assessment
Demographic variables
Information collected about the participants was age and
gender, and clinical versus non-clinical sample.
CORE-OM scoring
The CORE-OM paper and pencil version was used. The
34 items cover and yield scale scores from the four
domains; Well-being (four items), Function (12 items),
Problems/symptoms (12 items) and Risk (6 items). The
time frame covered is the last week. Item-scores have
minimum value of 0 and maximum value 4. Eight items
are positively termed, and have reversed scoring. The
total score (All) is calculated from the mean of all 34
items, and an alternative total score (All minus Risk)
from the 28 non-risk items. All scores are calculated by
dividing the sum item score by the number of items
answered and multiplying the result by ten. The higher
the score, the more troubled the patient is. For the 12
item subscales, scale scores were calculated based on
the mean of the answered items (pro-rating) if no more
than three items are missing; while for the two shorter
sub-scales, only one item was allowed missing [4].
Measurement of psychological stress
The sub-sample of 81 students that participated in the
test-retest reliability trial also answered a question meant
to measure psychological stress, namely “Have you been
exposed to any psychological stress last week?” Response
categories were simply “Yes”, or “No”.
Statistical analyses
Exploratory factor analysis (EFA)
The clinical sample was split in two parts using the first
as an exploratory sample (Sample 1) and the second as a
hold-out validation sample (Sample 2). A principal com-
ponent analysis was conducted to extract principal com-
ponents. As the CORE-OM is presumed to represent
four domains, any range of one to four components was
extracted. Promax rotation was chosen to allow for
correlations among the component scores, which also
made an analysis of second order factors possible. Com-
ponent scores were saved using the regression method.
The different EFA models were then compared in the
validation sample using confirmatory factor analyses,
and compared with the Four CORE domains model
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proposed by Evans and colleagues [4], and a general (g)
factor model as described below.
Confirmatory factor analyses (CFA)
Seventeen of the 34 CORE-OM item scores were signifi-
cantly skewed (Z ranging from −3.6 to 12.2; M = 1.7).
Twenty-six items also indicated a non-normal kurtosis
(Z ranging from −8.7 to +8.1), and hence, considerable
multivariate kurtosis was present (Mardia’s = 48.8). As
non-normal distributions bias estimation by narrowing
the standard errors of the parameters, an asymptotic
covariance matrix was estimated using PRELIS [15] and
included as a weight matrix to adjust the error band.
Polychoric correlations were calculated instead of Pearson
correlations since ordinal scaling is a more realistic
assumption than interval scaling in a four-point Likert
scale. Robust maximum likelihood estimation was pro-
vided using Satorra-Bentler rescaled chi-square statis-
tics (SB χ2). A non-significant chi-square statistic imply
a perfectly fitting model, but as models almost always
are not an exact replica of reality, root mean square
error of approximation (RMSEA), standardized root
mean error (SRMR) and comparative fit indices (CFI)
were evaluated in addition to the SB χ2. Following Hu
and Bentler [16], and Marsh and colleagues [17],
RMSEA below < 0.06, SRMR < 0.08 and CFI above >
0.95 indicate a reasonably good model approximation.
The non-nested factor models (the four EFA models
and the Four CORE domains model) were compared by
putting most weight on the SB chi-square statistics and
on the Akaike’s information criterion (AIC), which indi-
cates the best combination of model fit and parsimony
[17]. AIC was calculated as follows: AIC = SBχ2 + 2p
(p = number of model parameters). The AIC hence
penalizes more advanced models. A lower AIC indicates
a better fit. The g-factor model represents a nested fac-
tor model as the CORE item variances are modelled as a
product of three latent variance components: a general
factor (g) explaining the variance across all items, one
or several specific factors explaining covariance patterns
between the CORE items (according to the EFA),
and an error component. A similar factor modelling
approach has previously been conducted for the
CORE by Lyne and colleagues [9], which explicate the
modelling strategy.
Calculations of test parameters
Face validity of a questionnaire is best measured by
acceptability, the percentage of items left unanswered. In
the British validation [8] the overall omission rate was
1.7% of all items; while in the Swedish validation a mean
omission rate of 0.44% was found.
SPSS version 18 was used for calculating basic statistics,
differences between groups, linear regression modelling
and test-retest reliability. For calculating a weighted
average cut-off point, the formula of Jacobson and Truax
[18] was employed:
MclinSDnorm þMnormSDclin
SDclin þ SDnorm
Results
Acceptability
In the non-clinical sample 92% completed all 34 items.
There were no single items that were uncompleted by
more than 1.7% of the sample. Using pro-rating for
persons with up to 3 items missing, 98.9% of the sample
was usable for a sum-score. In the clinical sample, 83.1%
completed all items, and no items were uncompleted by
more than 3.6% of the sample (i.e. 97.5% usable).
Domain score correlations
Two separate Pearson’s product moment correlation ma-
trixes for the sums of scores on the four CORE domain
sub-scales, one for the non-clinical and one for the clinical
sample are presented in Table 1. Only the clinical sample
was used for the principal components and confirmatory
factor analyses.
Exploratory factor analyses (EFA)
Thirteen cases had to be removed due to more than
10% missing data. Remaining missing values were re-
placed by multiple imputations using the expected max-
imum function in PRELIS. According to Kaiser’s criterion
(eigenvalues > 1), seven principal components could be
extracted. However, as the three last components (five to
seven) contained few items (three or less), a model of four
components represented the best combination of model
fit (R2 = 51.7%, i.e. explained variance) and parsimonious-
ness (four components). The component loadings are
presented in Table 2. The psychological distress items
loaded on the first principal component. Seven out of
eight positively phrased items, most of them from the
Table 1 Inter-correlations (Pearson’s r) between CORE
sub-scales in non-clinical and clinical samples
Functioning Risk Well-being
Non-clinical (n=460)
Symptoms/Problems 0.66** 0.37** 0.68**
Functioning 0.34** 0.71**
Risk 0.29**
Clinical (n=519)
Symptoms/Problems 0.72** 0.63** 0.74**
Functioning 0.62** 0.68**
Risk 0.58**
** p<0.001.
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Functioning domain, loaded on the second component.
The items that loaded on the third component concerned
dysfunctional relationships and self-blame. The fourth
component included items concerning violence, threats
and irritability towards others.
Saving the component scores and subjecting those to a
second EFA, thus representing an analysis of second order
components, revealed strong support for one general
component (eigenvalue = 2.19) and weaker support of a
second component (eigenvalue = .89). However, as the
second component had a high loading (0.99), and repre-
sented the three risk items of the fourth component, this
component provided a conceptually distinct additional
independent contribution.
Confirmatory factor analyses
In the validation sample, several factor models were
compared against each other, and against the null model
Table 2 Principal component analysis in clinical sample 1 (n = 257)
Principal components
CORE item # (sub-scale)1 1 2 3 4
5 (P) I have felt totally lacking in energy and enthusiasm .84
15 (P) I have felt panic or terror .70
11 (P) Tension and anxiety have prevented me doing important things .67
2 (P) I have felt tense, anxious or nervous .66
8 (P) I have been troubled by aches, pains or other physicalproblems .65
18 (P) I have had difficulty getting to sleep or staying asleep .63
17 (W) I have felt overwhelmed by my problems .62
20 (P) My problems have been impossible to put to one side .60
10 (F) Talking to people has felt too much for me .58
23 (P) I have felt despairing or hopeless .58 .35
14 (W) I have felt like crying .54
13 (P) I have been disturbed by unwanted thoughts or feelings .53
21 (F) I have been able to do most things I needed to .49 .35
19 (F) I have felt warmth and affection for someone -.39 .79
31 (W) I have felt optimistic about my future .70
9 (R) I have thought of hurting myself .64
4 (W) I have felt OK about myself .63
24 (R) I have thought it would be better if I were dead .62
12 (F) I have been happy with the things I have done .61
16 (R) I made plans to end my life .57 .31
3 (F) I have felt I have someone to turn to for support when needed -.33 .53 .32
32 (F) I have achieved the things I wanted to .52
27 (P) I have felt unhappy .33 .46
7 (F) I have felt able to cope when things go wrong .42
1 (F) I have felt terribly alone and isolated .39 .33
25 (F) I have felt criticised by other people .77
33 (F) I have felt humiliated or shamed by other people .74
30 (P) I have thought I am to blame for my problems and difficulties .36 .61
26 (F) I have thought I have no friends .55
28 (P) Unwanted images or memories have been distressing me .33 .54
6 (R) I have been physically violent to others .77
22 (R) I have threatened or intimidated another person .74
29 (F) I have been irritable when with other people .35 .48
34 (R) I have hurt myself physically or taken dangerous risks with my health .46
Eigenvalues 12.2 1.9 1.8 1.7
Explained variance (%) 35.8 5.6 5.4 4.9
Note. Total variance explained = 51.7 %. Component loadings < .30 are suppressed.
1Domain names: W = Subjective well-being, P = Problems/symptoms, F = Functioning, R= Risk.
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(no factor loadings estimated). Again, the four-factor
solution based on the EFA (model 4) from Table 2 re-
ceived better support than the one, two or three compo-
nent models (see Table 3). The model fit, according to
the RMSEA index, was however not good (.0759). The
Four CORE domains model as originally published by
Evans (model 5) [4] was significantly poorer in absolute
terms (worse SB χ2), but only slightly worse in terms of
the RMSEA. However, specification of a general (g) factor
(model 6) improved fit considerably both in absolute
terms (considerable drop in chi-square and in AIC) and
according to the RMSEA (.0605), now approaching a ten-
able model fit. By allowing factor side-loadings according
to the original Four CORE domains model (model 7),
model fit improved slightly more (RMSEA = .057). The
comparative fit index (CFI) was also adequately high
(.974). The loadings for the g and the specific factors of
model 7 are presented in Table 4. This model is illustrated
in Figure 1.
Finally, it was examined to what extent methodical
aspects affected the item responses, similarly as Lyne
and colleagues [9] examined. Two additional factors
were specified, for the positively and negatively framed
items, respectively. The loadings for each method factor
were constrained equal under the assumption that a
method effect should exert a relatively equal influence
on all items, but also in order to maximize degrees of
freedom given the medium sample size. Model fit did
not improve significantly (S-B χ2 = 5.27, p = .07). The
changes in the RMSEA and the CFI indices were barely
observable and the factor loadings were small, .08 for
the positively and .12 for the negatively framed items,
hence explaining about 1.2% of the variance. Control of
response bias was thus of less concern and dropped
from further interpretation.
Interpretation of factor loadings
The g factor (Table 4 and Figure 1) is the most import-
ant dimension, as it explains most of the variance in the
CORE items. For the items assessing the ‘Problem/
Symptoms’ factor, two-thirds of the variance was
explained by the g, and one-third by its specific factor.
Two-thirds of the variance in the items assessing func-
tioning, was also explained by the g, while 14 and 17 per-
cent were explained by the specific factors ‘Functioning’
and ‘Well-being’, respectively. For the ‘Well-being’ items,
however, two-thirds was explained by g, and the remaining
variance was partly explained by the specific ‘Problems/
Symptoms’ and ‘Functioning’ factors. Thus, it was not
possible to validate the CORE subjective well-being
domain. However, there seems to be a common pattern of
low self-regard and interpersonal problems in the items
from the Problems/Symptoms and Functioning domain
that loads on the “well-being” factor.
About 62 percent of the variance in the risk items was
explained by the g factor. However, three of the risk
items, which are inherent in internalising problems,
signalling self-harm and thoughts of suicide (e.g.,
thoughts of hurting myself, suicidal ideation, or making
plans for suicide) were most strongly explained by g,
while the three externalizing, or acting out, risk items
(e.g., hurt myself physically or taken dangerous risks,
being physically violent, and threatening against other
people), were most strongly explained by the specific
‘Risk’ factor. This demonstrates that the classical sui-
cidal and self-harm risk items are important indicators
of general psychological distress, while the three acting
out risk items should be assessed independently of the
sum or g score. This interpretation is in line with the
second order EFA above, which supported interpreting
the fourth component (representing the same three risk
items) as independent from the other component.
Internal consistency
The internal consistency of the CORE-OM is presented
in Table 5. For both total scores and separate domains
consistency was generally high. The lowest internal
consistency was found for the risk domain in the non-
clinical sample, while the α of the risk domain was
significantly higher in the clinical sample.
Table 3 Comparisons of factor models using Structural Equation Modelling (SEM) in clinical sample 2 (n = 257)
Model df χ2 SB χ2 AIC RMSEA CFI
0: Null model 561 15610.0 15010.0 15077.9 .3172 .040
1: One factor 527 2374.8 1778.4 1914.4 .0963 .917
2: Two factors 526 1963.7 1457.4 1595.4 .0831 .938
3: Three factors 524 1890.2 1360.8 1502.8 .0790 .944
4: Four factors 521 1784.7 1289.2 1437.2 .0759 .949
5: Four CORE domains 521 1854.7 1367.5 1515.5 .0797 .944
6: Four factors +g 493 1347.4 953.3 1157.3 .0605 .969
7: Four factors +g+ Four CORE domains1 477 1235.1 876.4 1112.4 .0572 .974
Notes. Factor scores were allowed to correlate in models 1–5. In model 6 factor scores are specified as independent, due to the general factor explaining factor
covariance. 1 Same model as in Table 4 and Figure 1.
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Test-retest reliability, and effect of Norwegian versus
English language versions
For test-retest reliability calculations, stability of the same
language versions of the CORE (Norwegian-Norwegian),
filled in one or two weeks apart by the 81 students
participating in the language experiment was used. In
Table 6, test-retest stability of domain and total scores
for the Norwegian language version is shown. For all
domains, except the risk domain, the stability was
moderately high. Test-retest stability for the language
Table 4 Results from a SEM analysis specifying a g factor and the four CORE domains in clinical sample 2 (n = 257)
Common factors
CORE items P1 F W R g
2 (P) I have felt tense, anxious or nervous .50 .58
5 (P) I have felt totally lacking in energy and enthusiasm .47 .43
8 (P) I have been troubled by aches, pains or other physical problems .35 .20
11 (P) Tension and anxiety have prevented me doing important things .41 .50
13 (P) I have been disturbed by unwanted thoughts or feelings .28 .58
15 (P) I have felt panic or terror .52 .41
18 (P) I have had difficulty getting to sleep or staying asleep .22 .39
20 (P) My problems have been impossible to put to one side .38 .36
23 (P) I have felt despairing or hopeless .25 .74
27 (P) I have felt unhappy .26 (−.03) .75
28 (P) Unwanted images or memories have been distressing me .20 (.17) .49
30 (P) I have thought I am to blame for my problems and difficulties .01 (.24) .50
R2 .12 .00 .01 .00 .27
1 (F) I have felt terribly alone and isolated .13 .47
3 (F) I have felt I have someone to turn to for support when needed .19 .37
7 (F) I have felt able to cope when things go wrong .26 .69
10 (F) Talking to people has felt too much for me (.40) .21 .39
12 (F) I have been happy with the things I have done .39 .69
19 (F) I have felt warmth and affection for someone .14 .31
21 (F) I have been able to do most things I needed to (.08) .20 .49
25 (F) I have felt criticized by other people .19 (.60) .40
26 (F) I have thought I have no friends .13 (.39) .43
29 (F) I have been irritable when with other people .31 (.35) .18
32 (F) I have achieved the things I wanted to .19 .63
33 (F) I have felt humiliated or shamed by other people .14 (.50) .40
R2 .01 .05 .06 .01 .23
4 (W) I have felt OK about myself (.45) -.11 .64
14 (W) I have felt like crying (.21) -.01 .48
17 (W) I have felt overwhelmed by my problems (.51) -.04 .60
31 (W) I have felt optimistic about my future (.16) -.19 .59
R2 .08 .06 .01 .00 .34
6 (R) I have been physically violent to others .69 .36
9 (R) I have thought of hurting myself (−.31) .06 .82
16 (R) I made plans to end my life (−.39) .08 .81
22 (R) I have threatened or intimidated another person .76 .32
24 (R) I have thought it would be better if I were dead (−.19) .05 .85
34 (R) I have hurt myself physically or taken dangerous risks with my health .49 .59
R2 .00 .05 .00 .22 .44
Notes. R2 = Explained variance (%). Factor loadings in parentheses were estimated as specified by the principal component analysis (from Table 2).
1 Domain names: P =Symptoms/ Problems, W= Subjective well-being, F = Functioning, Risk=Risk, g = General factor.
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rotation experiment was also studied. By Pearson’s r,
test-retest reliability in the language rotation experiment
ranged between 0.50 to 0.87 for the All items score of
Norwegian version, and between 0.74 and 0.87 for the
English version. In multiple regression analyses, with
sex, age, language, and psychological stress as predic-
tors, language was only a significant predictor of total
CORE score at the fourth filling-in (β=0.27, p=0.01).
On all other occasions, the effect of language was non-
significant.
Figure 1 Illustration of best fitting model1 in Confirmatory Factor Analysis. 1 Same as model 7 in Table 3 and the model presented in
Table 4. Legend: Symptoms= Symptoms/ Problems, Function= Functioning, Well= Well-being, Risk= Risk, g-fact = g-factor. Numbers in squares
are item numbers in the CORE-OM.
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Gender and age differences
Table 7 shows the mean and standard deviations for the
four domain-scores, for the non-risk items, and for the
total (All items). With only two exceptions, there were
no significant differences in mean-scores between the
sexes, neither in the non-clinical nor in the clinical
sample. In the non-clinical sample the mean score was
significantly higher in women. The score for risk in the
clinical sample was significantly higher in men.
All mean scores were significantly higher in the clinical
than in the non-clinical sample.
To check whether differences between clinical and
non-clinical samples were influenced by the differences
in age and gender distribution in the two samples,
stepwise linear regression modelling was performed.
The results are presented in Table 8.
The highest proportion of the variance for all CORE
scores, both sub-domain and sum scores, was accounted
for by current patient status (i.e. belonging to the Clinical
sample). In addition to current patient status, younger age
accounted for part of the variance in Functioning and
Risk. Furthermore, being a woman predicted worse
Well-being scores, and being a man predicted higher
Risk scores. However the difference between the two
samples was mainly accounted for by current patient
status, while age and gender distribution had some, but
negligible effects.
Clinical Cut-off scores
The cut-off scores for clinical significant change are
presented in Table 9. Women had higher scores on well-
being (i.e.: feeling less well). Otherwise cut-off scores
were fairly equal for men and women.
The influence of psychological stress
To further study the validity of the cut-off scores for clin-
ical significant change, the sub-sample of 81 students that
participated in the four week language rotation experi-
ment were each week asked “Have you been exposed to
any psychological stress last week?”. For all domains, in
the first week of the experiment, the CORE-OM scores
differed according to whether the subjects reported ex-
periencing stress (Table 10). Those who experienced stress
had a total CORE-OM score (All items) almost exactly on
the clinical cut-off point.
The distributions of CORE-OM All items scores are
illustrated in Figure 2 showing the distributions of the
Clinical and Non-clinical total samples, and of the
students reporting psychological stress or not during
the preceding week.
As the figure illustrates, the clinical sample has a wide
distribution, covering the whole spectrum of CORE-
scores, with the vast majority of cases well above 1.0. On
the other hand, the non-clinical sample has a wide and
somewhat skewed distribution, with a thin “arm” reaching
well into the clinical population. However the vast major-
ity of the non-clinical sample has CORE-scores well below
1.0. The student sample was separated by the “stress”-
item. Students reporting no stress were almost all well
below clinical cut-off, while students reporting stress
formed a bimodal distribution, the larger peaking close
to CORE-score 1.0, while the smaller peak coincided
Table 5 Internal consistency, Chronbach’s α (95% CI), for non-clinical and clinical samples
Domain Non-clinical (n=473) Clinical (n=528)
Subjective well-being (4 items) 0.74 (0.70-0.78) 0.70 (0.66-0.74)
Symptoms / Problems (12 items) 0.84 (0.82-0.86) 0.87 (0.85-0.88)
Functioning (12 items) 0.82 (0.80-0.85) 0.84 (0.81-0.86)
Risk (6 items) 0.68 (0.63-0.72)* 0.81 (0.78-0.83)*
Non-risk items (28 items) 0.92 (0.91-0.93) 0.93 (0.92-0.94)
All items (34 items) 0.92 (0.91-0.93) 0.94 (0.93-0.95)
*p<0.05 (significantly higher α in clinical sample).
Table 6 Test-retest stability in non-clinical sample of 81 students
Well-being Symptoms/ Problems Functioning Risk Non-risk items All items
Well-being 0.631*
Symptoms/ Problems 0.69*
Functioning 0.70*
Risk 0.35*
Non-risk items 0.76*
All items 0.76*
1 Correlations between domain scores (Spearman’s rho).
*p<0.01.
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with the mode of the clinical sample. The Norwegian
translation is presented alongside the English original
CORE-OM in Table 11. The items are ordered
according to the originally proposed domains and
sub-domains.
Discussion
The main finding of this study was that the CORE-OM
in Norwegian translation can be seen as an instrument
measuring a g factor of psychological distress and sim-
ultaneously confirming subordinated factors measuring
problems, functioning and risk domains. The content of
the original last theorized domain, well-being, could not
be confirmed in our data. On the other hand, a domain
concerning low self esteem and interpersonal problems
emerged. Our findings also support simplifying the
communication of CORE-scores into two: Psychological
distress and Risk.
Furthermore we found that both the internal consistency
and the test-retest stability of the CORE-OM were
acceptable, and compared well with the original English
normative data. We also found that language version
had no or only negligible influence on CORE-scores in
a bilingual student sample. Finally, the clinical cut-off
points in the Norwegian samples were fairly equal to
the English norms. The proposed clinical cut-off point
of 1.0 was further validated, by demonstrating that sub-
jects reporting no psychological stress were separated
from those reporting psychological stress. Thus, our
findings did not support that CORE-OM fully measures
the domains suggested by the phase model of psycho-
therapy [4,6]. The original Four CORE domains model
as proposed by Evans [4] received poor support, due to
several items loading on other factors than theoretically
intended. As can be seen from the results of the EFA
(principal components analysis), and the confirmatory
factor analyses, when controlling for the g factor, the
originally proposed problem/symptom items that loaded
on the problems/symptoms component related to anx-
iety and distress. Furthermore, the originally proposed
functioning items that still retained some variance in a
secondary functioning factor related to everyday coping
and lack of positive affect. Interestingly, the original
well-being domain was not confirmed in our data, and
Table 7 Mean (M) and gender differences in scores for non-clinical and clinical sample
Domain Non-clinical Clinical
Male Female Total Male Female Total
n=130 n=330 N=440 n=206 n=313 n=529
M SD M SD 95 % CI1 M2 SD M SD M SD 95 % CI1 M2 SD
Well-being 0.74 0.60 0.98 0.67 0.11 – 0.37* 0.92 0.66 2.16 0.79 2.29 0.79 −0.00 – 0.80 2.25** 0.79
Symptoms 0.76 0.54 0.85 0.57 −0.02 – 0.21 0.83 0.56 2.25 0.79 2.25 0.75 −0.12 – 0.15 2.26** 0.77
Functioning 0.73 0.50 0.76 0.45 −0.07 – 0.12 0.76 0.47 1.75 0.66 1.69 0.64 −0.18 – 0.06 1.71** 0.65
Risk 0.09 0.23 0.06 0.19 −0.07 – 0.01 0.07 0.20 0.76 0.81 0.52 0.63 −0.37 – 0.13* 0.62** 0.71
Non-risk 0.74 0.48 0.83 0.49 −0.07 – 0.19 0.81 0.49 2.03 0.68 2.01 0.64 −0.12 – 0.11 2.03** 0.66
All items 0.60 0.42 0.69 0.41 −0.03 – 0.16 0.68 0.42 1.80 0.66 1.75 0.60 −0.16 – 0.06 1.78** 0.63
1 95% confidence interval for difference between male and female scores.
2 Means in non-clinical and clinical samples compared by t-test, significance of differences reported in M column for clinical sample.
*p<.001, **p<.0001.
Table 8 Stepwise linear regression analyses for CORE scores and domains, controlling for gender, age and clinical
status
Dependent variable in model
Independent variables3 Well-being1 Symptoms Functioning Risk Non-risk All items
β2 p< β p< β p< β p β p β p
Gender 0.08 .001 0.02 n.s. −0.02 n.s. −0.14 .0001 0.02 n.s. 0.00 n.s.
(Male=0, female=1)
Age −0.04 n.s. 0.00 n.s. −0.06 .05 −0.11 .0001 −0.30 n.s. −0.04 n.s.
Patient status 0.69 .0001 0.73 .0001 0.65 .0001 0.46 .0001 0.73 .0001 0.72 .0001
(Non-clinical=0, Clinical=1)
1 Model fit statistics (ANOVA) with df=3 for all models: Well-being: F=279.1, p<.0001; Symptoms/ Problems: F=363.7, p<.0001; Functioning: F=232.3, p<.0001; Risk:
F= 98.6, p<.0001; Non-risk: F= 352.1, p<.0001; All items: F= 338.0, p<.0001.
2 β Standarized Beta of independent variables.
3 Variables entered stepwise in order: Gender + Age+ Patient status.
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instead an interpersonal problems factor emerged.
Finally the risk domain separated into risk to self and
risk to others, of which the risk to self -items loaded
strongly on the g factor of psychological distress, while
the risk to others items loaded most strongly on a separate
risk factor. The more ambiguous risk item, concerning risk
taking, loaded almost equally on the g and the risk factors.
Interestingly, the g factor, as well as the problems,
functioning and risk factors correspond well with the
“state” concept of psychopathology [11]. On the other
hand, the items clustering around the interpersonal
relations theme are more in line with a trait concept,
since the content of these items could be attributed to
stable problems of personality [11]. However, contrary
to Bedford and colleagues [10], we do not find this
seeming mixture of state and trait items in the CORE-OM
problematic. Personality traits are unlikely to change
much in psychotherapy, and could be regarded redundant
in an outcome measure. On the other hand, endorsement
of the same items could indicate that the patient is
living in a pathogenic relationship or environment.
Since the CORE-OM is intended to be a general clinical
outcome instrument, which can give the clinician useful
hints about the problem profile of the patient, scoring
on the low self esteem and problematic interpersonal
relation items should lead to exploration of depression,
personality problems, living conditions, interpersonal
relations, and trauma history. Thus our recommenda-
tion to clinicians is to give attention not only to total
and to separate domains, but also to separate items
scores when using CORE-OM.
However, since the variance of the majority of the
CORE items was most strongly related to the g factor,
the creation of a single sum score to assess symptom
load appears adequate for effective clinical communica-
tion, rather than creating four separate subscale sum
scores, which are highly correlated, as well. Also, the risk
items should be consulted independently. Our findings
were in accordance with Lyne and colleague’s [9],
who proposed that CORE-scores should be communi-
cated through two scores: General psychological distress
and risk.
Table 9 Cut-off scores between clinical and non-clinical
samples in men and women
Men Women
Well-being 1.34 1.58
Symptoms / Problems 1.35 1.46
Functioning 1.16 1.14
Risk 0. 22 0.28
Non-risk items 1.26 1.34
All items 1.08 1.12
Table 10 Difference in CORE scores (ANOVA) between students who reported experiencing psychological stress, or no
stress last week (N=81)
Anova
Domain Stress N Mean SD 95% C I for Mean F p
Well-being Stress 13 1.28 0.44 1.02-1.56 14.124 0.000
No stress 68 0.68 0.55 0.54-0.81
Symptoms/Problems Stress 12 1.16 0.43 0.88-1.43 8.170 0.005
No stress 68 0.75 0.46 0.64-0.86
Functioning Stress 13 1.09 0.39 0.86-1.33 17.571 0.000
No stress 68 0.64 0.35 0.56-0.73
Risk Stress 13 0.30 0.51 −0.01-0.60 10.526 0.002
No stress 68 0.05 0.16 0.01-0.09
Non-risk items Stress 13 1.17 0.36 0.95-1.39 19.950 0.000
No stress 68 0.69 0.39 0.60-0.79
All items Stress 13 1.02 0.36 0.80-1.23 18.665 0.000
No stress 68 0.58 0.33 0.50-0.66
Figure 2 Distributions of CORE-OM (All items) scores in clinical
and non-clinical samples, and in students reporting stress, or
no stress, during last week.
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In the present validation study of the Norwegian
CORE-OM, we studied psychometric properties as
acceptability, internal consistency, test-retest stability,
and the differences between scores in non-clinical and
clinical samples. These properties were considered
comparable with the results from validation studies in
England [8,14], Sweden [7], Italy and Japan [12,13]. The
present cut-off scores were also in line with previous
results. Connell and colleagues [14] recommended a
cut-off score of 1.0 for the total score irrespective of
Table 11 The CORE-OM items in English and Norwegian translation, sorted after domain and sub-domains, and with
item number
Domain Item English original Norwegian translation
Over the last week. . . I løpet av den siste uken. . .
W 41 I have felt OK about myself Har jeg følt meg fornøyd med meg selv
W 14 I have felt like crying Har jeg hatt lyst til å gråte
W 17 I have felt overwhelmed by my problems Har jeg følt meg overveldet av mine problemer
W 311 I have felt optimistic about my future Har jeg følt meg optimistisk med tanke på framtiden
P-anxiety 2 I have felt tense, anxious or nervous Har jeg følt meg anspent, engstelig eller nervøs
P-anxiety 11 Tension and anxiety have prevented me doing important things Har anspenthet og angst hindret meg i å gjøre viktige ting
P-anxiety 15 I have felt panic or terror Har jeg følt redsel eller panikk
P-anxiety 20 My problems have been impossible to put to one side Har det vært umulig å legge bort problemene mine
P-
depressed
5 I have felt totally lacking in energy and enthusiasm Har jeg følt meg helt uten energi og entusiasme
P-
depressed
23 I have felt despairing or hopeless Har jeg følt meg fortvilet eller uten håp
P-
depressed
27 I have felt unhappy Har jeg følt meg ulykkelig
P-
depressed
30 I have thought I am to blame for my problems and difficulties Har jeg tenkt at mine problemer eller vanskeligheter var min
egen skyld
P-physical 8 I have been troubled by aches, pains or other physical problems Har jeg vært plaget av verk, smerter eller andre fysiske plager
P-physical 18 I have had difficulty getting to sleep or staying asleep Har jeg hatt problemer med å sovne eller har våknet fort igjen
P-trauma 13 I have been disturbed by unwanted thoughts or feelings Har jeg vært plaget av uønskede tanker eller følelser
P-trauma 28 Unwanted images or memories have been distressing me Har uønskede bilder eller minner plaget meg
F-general 71 I have felt able to cope when things go wrong Har jeg følt meg i stand til å takle det når noe har gått galt
F-general 121 I have been happy with the things I have done Har jeg vært fornøyd med det jeg har gjort
F-general 211 I have been able to do most things I needed to Har jeg klart å gjøre det meste av det jeg hadde behov for å
gjøre
F-general 321 I have achieved the things I wanted to Har jeg fått til det jeg ville
F-close 1 I have felt terribly alone and isolated Har jeg følt meg forferdelig alene og isolert
F-close 31 I have felt I have someone to turn to for support when needed Har jeg følt at jeg hadde noen å støtte meg til når jeg trengte
det
F-close 191 I have felt warmth and affection for someone Har jeg følt varme og hengivenhet overfor noen
F-close 26 I have thought I have no friends Har jeg tenkt at jeg ikke hadde noen venner
F-social 10 Talking to people has felt too much for me Har det å snakke med folk vært for mye for meg
F-social 25 I have felt criticised by other people Har jeg følt meg kritisert av andre
F-social 29 I have been irritable when with other people Har jeg vært irritabel mot andre mennesker
F-social 33 I have felt humiliated or shamed by other people Har jeg følt at andre har ydmyket meg eller gjort meg skamfull
R-self 9 I have thought of hurting myself Har jeg tenkt på å skade meg selv.
R-self 34 I have hurt myself physically or taken dangerous risks with my
health
Har jeg skadet meg selv fysisk eller tatt farlige sjanser med min
egen helse
R-suicidal 16 I made plans to end my life Har jeg lagt planer for å gjøre slutt på livet mitt
R-suicidal 24 I have thought it would be better if I were dead Har jeg tenkt det ville vært bedre om jeg var død
R-others 6 I have been physically violent to others Har jeg vært fysisk voldelig mot andre
R-others 22 I have threatened or intimidated another person Har jeg truet eller skremt et annet menneske
W= Well-being; P= Symptoms/ Problems; F= Functioning; R= Risk; 1 Reversed scoring.
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gender. They argue that since psychological distress is a
matter of degree, and not a discrete phenomenon, any
cut-off score will to some degree be arbitrary. Interest-
ingly, no substantial gender differences were found in
our clinical data, other than for the higher risk scores in
men. Correspondingly we can assume that men and
women when psychologically distressed experience
much the same load of problems.
Our data, comparing the scores of students reporting
psychological stress to those reporting no stress, confirms
that 1.0 is a valid cut-off point separating those who are
in distress from those who are relatively unaffected by
psychological problems. Based on our data, the cut-off
scores for the CORE-OM in Norway correspond to the
English norms.
Strengths and limitations
The strengths of this study were the large sample of out-
patients from Norwegian mental health services, the con-
firmatory factor analysis, the alternate language versions
experiment, and the measurement of psychological stress.
Some possible limitations should however be noted.
The non-clinical sample was collected among friends of
employees at out-patient clinics, and among students of
medicine and psychology. This means that the sample is
probably not representative of the Norwegian population.
The sample most probably consists of persons with a
somewhat higher social status than the population, and as
such, probably with better mental health.
Differences in age and gender distribution between the
clinical and non-clinical samples could confound both the
differences between the two samples and the calculated
cut-off points for clinical significant change. Regression
analysis did however demonstrate that even though
age and gender did contribute to the variance for some
sub-scores, currently being a patient was the strongest
predictor of differences between members of the two
samples.
The language rotation experiment resulted in finding
that language version did affect the scores on the fourth
and last occasions of filling in the questionnaire. Thus
our findings did not rule out the possibility of language
or translation having influenced the results.
Although a measurement of psychological stress was
introduced in the sample of students, no specification of
the nature of stress was obtained.
No convergent validation towards other clinical mea-
sures was performed. Since our sample was collected
anonymously from different populations, we did not
have data for cross-validation. However, the CORE-OM
in Swedish, English, Italian and Japanese has been
cross-validated with other measures like the BDI, BAI,
GHQ and SCL [7,8,12,13], and another cross-validation
seems redundant.
Conclusions
The Norwegian translation of the CORE-OM have psy-
chometric properties at the same high level as the English
original, and could be recommended for general clinical
use in out-patient populations. The present study provided
most support for a general factor (g) underlying the
CORE-OM items, while the sub-domain factors were less
distinctively defined. Moreover, the risk items for harm
should be consulted separately. For easy clinical commu-
nication we recommend that both the total CORE-OM
scores and the risk scores should be flagged.
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